SuperSonic Imagine announced that a multicenter retrospective study conducted in Europe and China, has confirmed the clinical utility of ShearWave Elastography in patients with chronic liver disease, the first results of which were presented at the International Liver Congress (ILC 2019). The objective of this study was to evaluate the diagnostic value of ShearWave Elastography (SWE) in the progression of chronic liver disease and in the development of associated complications. SWE is an innovative imaging mode developed by SuperSonic Imagine, which enables the visualization and measurement of tissue elasticity. The measurement of hepatic elasticity, displayed in kilopascals (kPa), is a well-established technique for assessing the severity of fibrosis in patients with chronic liver diseases. This criterion has become an important parameter for determining the degree of progression of the disease. However, the value of shear-wave based elastography for predicting mortality in cirrhotic patients has hitherto remained undetermined. The study conducted in 15 centers in Europe and China included 1434 patients with a median age of 55 years, 58% of whom were men. Inclusion criteria were the presence of chronic liver disease with a SWE measurement at the onset of the disease, no previous decompensation event, and at least one year of clinical follow-up after the SWE measurement (median follow-up 34.8 months). About a year ago, SuperSonic Imagine released its new Aixplorer MACH® 30 Hepato that integrates the full range of imaging modes and is believed to represent the industry standard in hepatology with its elastography ShearWave PLUS, which allows real-time visualization and measurement of tissue stiffness. The Aixplorer MACH 30 also offers ‘B-mode Ratio’ for detecting intrahepatic steatosis, Angio PL.U.S. to provide unparalleled resolution for the imaging of microvascularisation of lesions, and also Doppler and contrast imaging, for the screening and characterization of liver nodules. Liver applications remain strategic for SuperSonic Imagine and with its new generation of UltraFast imaging introduced on the Aixplorer MACH 30, the company is continuing its development of new ultrasound markers for the liver.